Your browser doesn't support javascript.
loading
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.
Ramsauer, Katrin; Schwameis, Michael; Firbas, Christa; Müllner, Matthias; Putnak, Robert J; Thomas, Stephen J; Desprès, Philippe; Tauber, Erich; Jilma, Bernd; Tangy, Frederic.
Afiliação
  • Ramsauer K; Themis Bioscience GmbH, Vienna, Austria.
  • Schwameis M; Department of Clinical Pharmacology, Medical University of Vienna, Austria, Europe.
  • Firbas C; Department of Clinical Pharmacology, Medical University of Vienna, Austria, Europe.
  • Müllner M; Themis Bioscience GmbH, Vienna, Austria.
  • Putnak RJ; Walter Reed Army Institute of Research, Viral Diseases Branch, Silver Springs, MD, USA.
  • Thomas SJ; Walter Reed Army Institute of Research, Viral Diseases Branch, Silver Springs, MD, USA.
  • Desprès P; Department of Infections and Epidemiology, Institut Pasteur, La Réunion, UMR U1187 PIMIT (I2T), France.
  • Tauber E; Themis Bioscience GmbH, Vienna, Austria.
  • Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Austria, Europe. Electronic address: bernd.jilma@meduniwien.ac.at.
  • Tangy F; Viral Genomics and Vaccination Unit, Institut Pasteur, Paris, CNRS UMR-3569, France.
Lancet Infect Dis ; 15(5): 519-27, 2015 May.
Article em En | MEDLINE | ID: mdl-25739878
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Vírus Chikungunya / Anticorpos Neutralizantes / Febre de Chikungunya / Vírus do Sarampo / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Vírus Chikungunya / Anticorpos Neutralizantes / Febre de Chikungunya / Vírus do Sarampo / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article